Sign in

CIK 0001601485

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Elicio Therapeutics, Inc.

Sign in to watch
Ticker
ELTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
113430072
Phone
+1 857-209-0050
Business address
451 D STREET, 5TH FLOOR, BOSTON, MA, 02210
Former names
Angion Biomedica Corp.
  1. 4 Other disposition 10% owner disposed of 913,659 shares (other)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Open-market sale Neylan John F. sold 381 shares at $9.03 ($3,440)
  4. 4 Open-market sale Rhodes Jennifer J sold 445 shares at $10.68 ($4,753)
  5. 4 Open-market sale Rhodes Jennifer J sold 432 shares at $10.94 ($4,726)
  6. 4 Open-market sale Neylan John F. sold 365 shares at $10.98 ($4,008)
  7. 4/A Insider Changes in Ownership
  8. 4 Open-market sale Rhodes Jennifer J sold 431 shares at $11.01 ($4,745)
  9. 4 Open-market sale Neylan John F. sold 366 shares at $13.20 ($4,831)
  10. 4 Open-market sale Rhodes Jennifer J sold 427 shares at $13.27 ($5,666)
  11. 4 Open-market sale Neylan John F. sold 363 shares at $13.91 ($5,049)
  12. 4 Open-market sale Rhodes Jennifer J sold 440 shares at $13.92 ($6,125)
  13. 4 Open-market sale Neylan John F. sold 381 shares at $13.55 ($5,163)
  14. 4 Open-market sale Rhodes Jennifer J sold 399 shares at $15.01 ($5,989)
  15. 4 Open-market sale Neylan John F. sold 442 shares at $19.13 ($8,455)
  16. 4 Open-market sale Rhodes Jennifer J sold 499 shares at $20.45 ($10,205)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 6 of 7 · 140 filings